000			01753 a2200481 4500
005			20250514164406.0
264		0	_c20040420
008			200404s 0 0 eng d
022			_a0305-7453
024	7		_a10.1093/jac/dkh041 _2doi
040			_aNLM _beng _cNLM
100	1		_aHearn, Michael J
245	0	0	_aDesign and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cFeb 2004
300			_a185-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAntitubercular Agents _xchemical synthesis
650	0	4	_aBiological Availability
650	0	4	_aChlorocebus aethiops
650	0	4	_aCulture Media
650	0	4	_aDrug Design
650	0	4	_aEscherichia coli _xdrug effects
650	0	4	_aFemale
650	0	4	_aIndicators and Reagents
650	0	4	_aInjections, Intravenous
650	0	4	_aIsoniazid _xanalogs & derivatives
650	0	4	_aMass Spectrometry
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSalmonella _xdrug effects
650	0	4	_aSchiff Bases
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
650	0	4	_aVero Cells
700	1		_aCynamon, Michael H
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 53 _gno. 2 _gp. 185-91
856	4	0	_uhttps://doi.org/10.1093/jac/dkh041 _zAvailable from publisher's website
999			_c14419448 _d14419448